Draft Guidance for Industry and Food and Drug Administration Staff; Mobile Medical Applications; Availability
Document ID: FDA-2011-D-0530-0001
Comments
Total: 85
-
The Lucidicus Project - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0004 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Anonymous - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0005 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Richard H Epstein - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0006 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Richard H Epstein - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0007 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Richard H Epstein - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0008 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Daniel Chaim Ginsberg - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0009 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Long Nguyen - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0010 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Joseph Shavit - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0014 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Anonymous - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0015 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
David Kipp, PT - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0016 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Gloria M HERRMANN - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0017 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
David Stanger - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0018 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Daniel D Howie - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0019 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Luis A. Frigo - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0020 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Yan Hong - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0021 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Osman Ouattara- Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0022 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Anonymous - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0023 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Ramon Leroy Sanchez - Comment
Posted : 08/16/2011 ID ：FDA-2011-D-0530-0024 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Madeline E. Pantalone - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0530-0026 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Jerusalem Walker - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0530-0027 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Madeline E Pantalone - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0530-0028 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Sharon Larson - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0530-0029 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Simulconsult, Inc. - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0530-0031 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
ROBERT ANDREW FABICH - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0530-0032 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Mentor Graphics - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0530-0033 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Gregory D Gogates - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0530-0034 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Peter Jan Ogrodnik - Comment
Posted : 09/27/2011 ID ：FDA-2011-D-0530-0036 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
ANN K MILLER - Comment
Posted : 10/26/2011 ID ：FDA-2011-D-0530-0040 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Electronic Health Record Association (EHRA) - Comment
Posted : 10/26/2011 ID ：FDA-2011-D-0530-0042 Agency : FDA -
Oct 19,2011 11:59 PM ET
-
Patricia Flatley Brennan - Comment
Posted : 10/26/2011 ID ：FDA-2011-D-0530-0043 Agency : FDA -
Oct 19,2011 11:59 PM ET